Eunjin Jo

Prof. Eunjin Jo

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2016 in Optical Materials
Verified
Journal Article
Closed access
Abhishek LokhandeAbhishek Lokhande
Abhishek Lokhande
Sachin A. PawarSachin A. Pawar
Sachin A. Pawar
EJEunjin Jo
Eunjin Jo
MHMingrui He
Mingrui He
ASA. Shelke
A. Shelke
JCJu H. Choi
Ju H. Choi

4 December 2025 in Current Oncology
Verified
Journal Article
Open access
PDF file
EJEunjin Jo
Eunjin Jo
KBKa Ryeong Bae
Ka Ryeong Bae
The study aimed to understand how patients with liver cancer experience and adapt to the fear of cancer recurrence, providing insights into psychological processes and strategies that can inform psycho-oncology research and interventions. In-depth interviews were conducted with 13 patients with liver cancer from December 2019 to February 2020 and analyzed using Colaizzi’s phenomenological method. Four theme clusters emerged: (1) “Inevitable reality of recurrence,” which highlighted the acceptance of recurrence; (2) “Amplified fears,” which reflected heightened emotional distress; (3) “Changes in daily life driven by fear,” which illustrated lifestyle changes driven by uncertainty; and (4) “Living with fear,” which described adaptive strategies and resilience. The findings highlight the need for targeted psycho-oncological approaches to address the fear of cancer recurrence in patients with liver cancer, supporting the development of resilience and enhancing their overall quality of life. Further research is essential to design tailored strategies that reduce psychological distress and promote long-term survivorship.

16 November 2022 in Scientific Reports
Verified
Journal Article
Open access
PDF file
EJEunjin Jo
Eunjin Jo
SKSanghee Kim
Sanghee Kim
HLHyangkyu Lee
Hyangkyu Lee
SLSeok Lee
Seok Lee
While hematopoietic stem cell transplantation (HSCT) has led to higher survival rates, the number of patients experiencing adverse reactions is also increasing. Based on the symptom management model, we aimed to analyze the relationships between symptom experience, symptom management strategies, self-management behavior, and quality of life among patients undergoing HSCT in South Korea and to identify the factors affecting their quality of life. The data of 67 conveniently sampled patients undergoing HSCT at a university-affiliated hospital, for the period from March 23 to June 7, 2016, were collected using a self-reported structured questionnaire. Data were analyzed using Pearson’s correlations and multiple regression analysis. Quality of life showed a significant negative correlation with symptom experience and significant positive correlations with symptom management strategies. Factors influencing quality of life included symptom distress, symptom management strategies, and self-management behavior; these explained 39.4% of the variance. To improve quality of life in patients undergoing HSCT, the efficient management of multiple co-existing symptoms is important. There is a need for tailored nursing interventions based on a patient-focused and person-centered approach for patients undergoing HSCT.

7 November 2025 in BMC Cancer
Verified
Journal Article
Open access
PDF file
KBKaryeong Bae
Karyeong Bae
EJEunjin Jo
Eunjin Jo
While most studies on hematopoietic stem cell transplantation (HSCT) have focused on its negative impact, recent research has highlighted the concept of post-traumatic growth (PTG), where individuals experience positive psychological changes after a traumatic event. However, research on PTG in HSCT recipients remains limited. This study aimed to examine PTG as the primary outcome among HSCT recipients and identify key psychosocial and clinical predictors. Adult HSCT recipients within 1 year of transplantation at a university hospital in Seoul were enrolled from March 2018 to March 2022. Participants completed structured questionnaires, and treatment-related data were extracted from electronic medical records. Data were analyzed using descriptive statistics, t-tests, analysis of variance, Pearson’s correlation, and multiple regression analysis. Overall, 106 patients were enrolled. The average PTG score was 73.75, with higher scores observed in autologous transplant recipients compared to those who received transplants from sibling and unrelated donor transplants. Significant factors influencing PTG included marital status (β=-2.91, p < .001), positive changes after transplantation (β=-0.196, p < .009), rumination (β = 0.298, p < .001), transplant type (β = 0.268, p < .001), and social support (β = 0.191, p < .006), with the regression model explaining 53% of the variance (F = 20.773, p < .001). Our findings underscore the need for tailored interventions that address key factors influencing PTG in HSCT recipients. They also highlight the essential role of oncology nurses in assessing psychosocial needs and implementing individualized, evidence-based care strategies to support psychological recovery and promote PTG.

1 January 2025 in Asian Oncology Nursing
Verified
Journal Article
Open access
PDF file
EJEunjin Jo
Eunjin Jo
SKSanghee Kim
Sanghee Kim
조은진, et al. Asian Oncol Nurs. 2025 Jun;25(2):39-52. https://doi.org/10.5388/aon.2025.25.2.39

30 June 2022 in Journal of the Korean Bioethics Association
Verified
Journal Article
Closed access
EJEunjin Jo
Eunjin Jo
SKSanghee Kim
Sanghee Kim
현재 우리 의료 현장은 환자의 생명 연장을 위한 의학 지식과 의료기술이 발전했으나 의료진과 환자/대리인 간의 생명 결정권에 관해 갈등으로 보이는 한계를 지니고 있다. 의료인과 환자/대리인 간의 생명 연장에 대한 견해 차이가 있으며 좁혀지지 못한 채 이에 대한 서로의 정당화를 위해서 의학적 무의미함의 개념을 종종 사용한다. 의학적 무의미함이란 환자에게 사용 가능한 의학적 치료가 더 이상 환자의 의학적 상태를 개선하지 않을 것으로 판단하고 이에 의학적으로 제안된 치료를 수행하지 않아야 함을 의미하고 있으나 여전히 의학적 무의미함은 각자의 입장의 차이로 인해 판단하는 점이 달라 윤리적으로 논란을 일으키고 있는 실정이다. 다양한 의료 상황에서 의학적 무의미함에 대한 합의가 이루어지기 어려우며 지속적인 치료가 환자에게 주는 이점에 대해 의료진과 환자, 환자 가족 사이에 종종 심각한 불일치를 보이고 있다. 그러나 의학적 무의미함에 대한 각자의 견해에서의 첨예한 대립을 고수하기보다는 의학적 무의미함이 의료진과 환자/대리인 사이에서 의사 결정을 최적화하는 전략으로 나아갈 필요가 있다. 본 논문에서는 현재까지의 의학적 무의미함에 대한 정의, 쟁점에 대해 알아본 후 의학적 무의미함에 대한 윤리적 판단기준에 대해 생각해보고 의료 현장에서 실천적인 접근을 위해 논의하고자 한다.